Table 2.
Effects of the intervention on the primary outcome (urinary incontinence symptom severity) at 2 months after randomization and 6 weeks post partum.
Study time | Follow-up time, mean (SD)a | Between-group differences, mean (95% CI) | P value | Linear mixed-effect model results (P valueb) | |||
|
Experimental group (n=63) | Control group (n=63) |
|
|
Time | Group | Group×time |
Baseline | 4.98 (4.01) | 4.30 (4.05) | N/Ac | N/A | N/A | .55 | N/A |
2 months after randomization | 2.52 (3.26) | 5.09 (4.35) | −2.86 (−4.09 to −1.64) | <.001 | .02 | N/A | <.001 |
6 weeks post partum | 1.85 (2.66) | 4.30 (4.38) | −2.68 (−3.87 to −1.49) | <.001 | .99 | N/A | <.001 |
aA higher score indicates a more severe urinary incontinence symptom.
bAdjusted for prepregnancy BMI, abortion history, delivery mode, and urinary incontinence during pregnancy.
cN/A: not applicable.